All lobbying filings

PERSONALIZED MEDICINE COALITION

Lobbying for PERSONALIZED MEDICINE COALITION · Health care

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $37,000.00 expenses · posted Jan 16, 2026

Official filing document

Bills named in this filing 8

HR 2471
Right Drug Dose Now Act of 2025
HR 6208
No Surrogacy for Sex Offenders Act
S 3607
Access to Genetic Counselor Services Act of 2026
HR 3514
Improving Seniors’ Timely Access to Care Act of 2025
S 1816
Improving Seniors’ Timely Access to Care Act of 2025
HR 5269
RESULTS Act
HR 1672
Maintaining Investments in New Innovation Act
S 832
EPIC Act of 2025

Lobbying activity 2

Health Issues

Congressional Personalized Medicine Caucus Genetic Testing and Genomic Sequencing for Rare Diseases H.R. 2471 Right Drug Dose Now Act H.R. 6208/S. 3607 Access to Genetic Counseling Services Act H.R. 3514 / S. 1816 Improving Seniors Timely Access to Care Act H.R. 5269/S. 2761Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act H.R. 1672 Maintaining Investments in New Innovation Act S. 832 Ensuring Pathways to Innovative Cures Act of 2025 Implementation of the Medicare Drug Price Negotiation (Public Law 117-169) Implementation of Rural Health Transformation Program (Public Law 119-21) Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community

Budget/Appropriations

FY 2026 Food and Drug Administration Budget Priorities for CDER, CBER and CDRH FY 2026 National Institutes of Health Budget Priorities Reauthorization of the Prescription Drug User Fee Act; PFUFA VIII Reauthorization of the Medical Device User Fee Act; MDUFA VI

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.